loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for r0_cep_2013_083___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 QILU ANTIBIOTICS (LINYI) PHARMACEUTICAL CO., LTD. Dezhou City CN (1)

filter

01 Warfarin sodium clathrate (1)

filter

01 China (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R0-CEP 2013-083 - Rev 00
Withdrawn by Holder
Chemical
2014-04-14
2018-11-06
699
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2013-083 - Rev 00 of Qilu Antibiotics (linyi) Pharmaceutical Co., Ltd. Dezhou City Cn

Looking for Certificates of Suitability (CEPs) for R0-CEP 2013-083 - Rev 00 of Qilu Antibiotics (linyi) Pharmaceutical Co., Ltd. Dezhou City Cn 1

20

Qilu Antibiotics (linyi) Pharmaceutical Co., Ltd. Dezhou City Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Warfarin sodium clathrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2013-083 - Rev 00

This Chemical Type CEP, issued on April 14, 2014, remains in force until November 06, 2018, ensuring its reliability within the pharmaceutical industry.

Substance Number 699 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY